Companies / Ionis Pharmaceuticals Inc / Activity
Activity — Ionis Pharmaceuticals Inc
77 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | O'Neil Patrick R. Executive | Sell | Common Stock | $763.7K | -10K -14.02% | 62,211 0.04% of shares | medium |
| Feb 13, 2026 | Swayze Eric Executive | Sell | Common Stock | $769.5K | -9K -19.76% | 38,312 0.02% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $783.9K | -9K -34.62% | 17,494 0.01% of shares | medium |
| Jan 16, 2026 | Hougen Elizabeth L Executive | Sell | Common Stock | $972.0K | -13K -9.28% | 126,307 0.08% of shares | medium |
| Mar 3, 2026 | Bennett C Frank Executive | Sell | Common Stock | $1.01M | -13K -13.49% | 81,356 0.05% of shares | medium |
| Mar 3, 2026 | Klein Joseph III Director | Sell | Common Stock | $1.07M | -14K -41.82% | 18,820 0.01% of shares | medium |
| Mar 3, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $1.13M | -14K -33.58% | 28,326 0.02% of shares | medium |
| Mar 3, 2026 | Diaz Allene M. Director | Sell | Common Stock | $1.17M | -15K -75.21% | 4,816 <0.01% of shares | medium |
| Mar 10, 2026 | Jenne Kyle Executive | Sell | Common Stock | $1.23M | -16K -57.86% | 11,714 <0.01% of shares | medium |
| Mar 10, 2026 | Monia Brett P CEO | Sell | Common Stock | $1.25M | -17K -5.97% | 260,253 0.16% of shares | medium |
| Mar 10, 2026 | Monia Brett P CEO | Sell | Common Stock | $1.34M | -18K -6.76% | 242,662 0.15% of shares | medium |
| May 4, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $1.34M | -18K -32.86% | 36,330 0.02% of shares | medium |
| Feb 2, 2026 | Bennett C Frank Executive | Sell | Common Stock | $1.37M | -16K -17.02% | 80,293 0.05% of shares | medium |
| Jan 2, 2026 | Swayze Eric Executive | Sell | Common Stock | $1.45M | -18K -37.58% | 30,453 0.02% of shares | medium |
| Apr 1, 2026 | Klein Joseph III Director | Sell | Common Stock | $1.52M | -20K -60.31% | 13,230 <0.01% of shares | medium |
| Mar 10, 2026 | Jenne Kyle Executive | Sell | Common Stock | $1.60M | -21K -43.25% | 27,800 0.02% of shares | medium |
| Feb 2, 2026 | Bennett C Frank Executive | Sell | Common Stock | $1.65M | -20K -19.94% | 80,293 0.05% of shares | medium |
| Jan 7, 2026 | Devers Shannon L. Executive | Sell | Common Stock | $2.18M | -26K -59.35% | 17,494 0.01% of shares | medium |
| Feb 6, 2026 | Monia Brett P CEO | Sell | Common Stock | $2.52M | -29K -10.37% | 254,497 0.15% of shares | medium |
| Mar 3, 2026 | Diaz Allene M. Director | Sell | Common Stock | $3.11M | -39K -66.90% | 19,424 0.01% of shares | medium |
| Jan 16, 2026 | Monia Brett P CEO | Sell | Common Stock | $3.29M | -44K -16.39% | 224,683 0.14% of shares | medium |
| Feb 2, 2026 | Bennett C Frank Executive | Sell | Common Stock | $4.04M | -49K -37.72% | 80,293 0.05% of shares | medium |
| May 4, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $4.46M | -60K -52.38% | 54,111 0.03% of shares | medium |
| Jan 30, 2026 | Monia Brett P CEO | Sell | Common Stock | $5.21M | -63K -18.15% | 283,927 0.17% of shares | medium |
| Mar 3, 2026 | Bennett C Frank Executive | Sell | Common Stock | $5.66M | -72K -43.23% | 94,043 0.06% of shares | medium |
| Mar 9, 2026 | Monia Brett P CEO | Sell | Common Stock | $8.85M | -118K -32.49% | 244,346 0.15% of shares | medium |
| Mar 16, 2026 | Hougen Elizabeth L Executive | Sell | Common Stock | $14.88M | -206K -66.78% | 102,272 0.06% of shares | high |